A phase IB study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: An Academic GI Cancer Consortium (AGICC) study

Authors

• S J. Cohen

Publication/Presentation Date

5-2012

Volume

30

Issue

15

Published In/Presented At

DOI: 10.1200/jco.2012.30.15_suppl.4052

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article